最新报道:iSpecimen (NASDAQ: ISPC) is developing a $200 million corporate treasury on Solana, engaging with crypto firms since August to explore tokenized assets and major cryptocurrencies. The strategy includes discounted SOL purchases via OTC transactions, staking for yields, and liquid staking tokenization to boost shareholder value. CEO Robert Lim emphasized diversification and long-term holding, with a small allocation for spot trading. Funding will come from capital raises, though potential dilution and execution risks are noted. The move marks a shift from its core biospecimen business, introducing volatility and regulatory uncertainties.